Biopharmazeutika Vertragsmarkt 2022 | Größe | Prognose bis 2030

Table of Content

1.Introduction

1.1.Market Introduction
1.2.Market Research Methodology
1.2.1.Research Process
1.2.2.Primary Research
1.2.3.Secondary Research
1.2.4.Data Collection Technique
1.2.5.Data Sources
1.3.Market Estimation Methodology
1.3.1.Limitations of the Study
1.4.Product Picture of Biopharmaceuticals Contract Manufacturing
1.5.Global Biopharmaceuticals Contract Manufacturing: Classification
1.6.Geographic Scope
1.7.Years Considered for the Study
1.8.Research Methodology in brief
1.9.Parent Market Overview
1.10. Overall Biopharmaceuticals Contract Manufacturing Market Regional Demand
1.11. Research Programs/Design
1.12. Market Breakdown and Data Triangulation Approach
1.13. Data Source
1.14. Secondary Sources
1.15. Primary Sources
1.16. Primary Interviews
1.17. Average primary breakdown ratio

2.Market Dynamics

2.1.Drivers
2.1.1.Drivers
2.2.Restraints
2.2.1.Restraints
2.3.Opportunity
2.3.1.Impact forces on market dynamics
2.3.2.Impact forces during the forecast years
2.4.Industry Value Chain
2.4.1.Upstream analysis
2.4.2.Downstream analysis
2.4.3.Distribution Channel
2.4.4.Direct Channel
2.4.5.Indirect Channel
2.5.Potential Customers
2.6.Manufacturing/Operational Cost Analysis
2.7.Pricing Analysis by Region
2.8.Key Technology Landscape
2.9.Regulatory Analysis
2.10. Porter\'s Analysis
2.10.1.Supplier Power
2.10.2.Buyer Power
2.10.3.Substitution Threat
2.10.4.Threat from New Entry
2.10.5.Competitive Rivalry
2.11. PESTEL Analysis
2.12. Political Factors
2.13. Economic Factor
2.14. Social Factors
2.15. Technological Factor
2.16. Environmental Factors
2.17. Legal Factor

3.Global Biopharmaceuticals Contract Manufacturing Market Segmentation, by Revenue (USD Billion), (2023-2030)

3.1.By Source
3.1.1.Mammalian
3.1.2.Microbial (Non-Mammalian)
3.2.By Product Type
3.2.1.Biologics
3.2.1.1.Monoclonal Antibodies (MAbs)
3.2.1.2.Recombinant Proteins
3.2.1.3.Vaccines
3.2.2.Antisense, RNAi, & Molecular Therapy
3.2.3.Biosimilars
3.3.By Service
3.3.1.Process Development
3.3.2.Fill & Finish Operations
3.3.3.Analytical & QC studies
3.3.4.Packaging
3.4.By Therapeutic Area
3.4.1.Autoimmune diseases
3.4.2.Metabolic Diseases
3.4.3.Cardiovascular Diseases
3.4.4.Oncology
3.4.5.Neurology
3.4.6.Infectious Diseases
3.4.7.Respiratory Diseases
3.4.8.Others

4.Global Biopharmaceuticals Contract Manufacturing Market Overview, By Region

4.1. North America Market Revenue (USD Billion), by Countries, (2023-2030)
4.1.1. US
4.1.1.1.By Source
4.1.1.2.By Product Type
4.1.1.3.By Service
4.1.1.4.By Therapeutic Area
4.1.2.Canada
4.1.3.Mexico
4.2.Europe Market Revenue (USD Billion), by Countries, (2023-2030)
4.2.1.France
4.2.2.UK
4.2.3.Germany
4.2.4.Spain
4.2.5.Russia
4.2.6.Italy
4.2.7.BENELUX
4.3.Asia Pacific Market Revenue (USD Billion), by Countries, (2023-2030)
4.3.1. China
4.3.2. Japan
4.3.3. Australia
4.3.4. South Korea
4.3.5. India
4.3.6. ASIAN
4.4.Latin America Market Revenue (USD Billion), by Countries, (2023-2030)
4.4.1. Brazil
4.4.2. Argentina
4.4.3. Chile
4.5.Middle East and Africa Market Revenue (USD Billion), by Countries, (2023-2030)
4.5.1.GCC
4.5.2.Turkey
4.5.3.South Africa

5.Global Biopharmaceuticals Contract Manufacturing Market Revenue: Competitive Analysis, 2021

5.1.Key strategies by players
5.2.Revenue (USD Billion and %), By manufacturers, 2022
5.3.Player Positioning by Market Players, 2022

6.Competitive Analysis

6.1.Lonza
6.1.1.Business Overview
6.1.2.Business Financials (USD Billion)
6.1.3.Product Category, Type, and Specification
6.1.4.Main Business/Business Overview
6.1.5.Geographical Analysis
6.1.6.Recent Development
6.1.7.Swot Analysis
6.2.Samsung BioLogics
6.3.Catalent Inc.
6.4.Boehringer Ingelheim International GmbH
6.5.Inno Biologics Sdn Bhd
6.6.Rentschler Biotechnologies GmbH
6.7.JRS Pharma
6.8.Tianjin Pharmaceutical
6.9.TCG Lifesciences
6.10.AGC Biologics
6.11.Dr. Reddy\'s Laboratories
6.12.ProBioGen
6.13.Jubilant Life Sciences
6.14.Juniper Pharmaceutical Services
6.15.Fujifilm Diosynth Biotechnologies U.S.A., Inc.
6.16.Toyobo Co., Ltd.
6.17.Pfizer Centreone
6.18.Piramal
6.19.Recipharm
6.20.Thermo Fisher Scientific, Inc.
6.21.WuXi Biologics
6.22.AbbVie, Inc.

7.Market Research Findings & Conclusion
Disclaimer

Disclaimer